14
Nov
2024
14:00
GMT
09:00
EST
Webinar
CV Manifestations With BTK, CAR-T and Immunotherapies
-
Views:
1246
-
Likes:
6
Overview
Join Dr Mazyar Shadman (University of Washington, US), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) as they explore the latest advancements and challenges in managing cardiovascular manifestations in patients undergoing targeted therapies like Bruton's Tyrosine Kinase (BTK) inhibitors, Chimeric Antigen Receptor T-cell (CAR-T) therapies and cutting-edge immunotherapies.
The faculty will discuss emerging evidence, clinical strategies and innovative treatments aimed at improving patient outcomes. Register now to secure your spot in this upcoming webinar focused on the intersection of cardiovascular health and modern immuno-oncology.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This webinar is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International Cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by Eli Lilly through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Faculty:
Mazyar Shadman
Dan Lenihan
Joe Carver
This webinar is supported by
Faculty Biographies
Mazyar Shadman
Dr Mazyar Shadman, MD, MPH, is the Innovators Network Endowed Chair and an Associate Professor at Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) in Seattle, he is also the Medical Director, Cellular Immunotherapy and Bezos Family Immunotherapy Clinic at the Fred Hutch. He is a hematologic malignancies expert who specialises in treating patients with lymphoma/CLL.
He is involved in clinical trials using novel therapeutic agents, cellular immunotherapy (CAR-T cell), and stem cell transplant for treatment of lymphoid malignancies. He also studies the clinical outcomes of patients using institutional and collaborative retrospective cohort studies. Dr Shadman received his MD from Tehran University in Iran. He finished internal medicine internship and residency training at the Cleveland Clinic in Cleveland, Ohio and completed his training in haematology and medical oncology fellowships at the UW and Fred Hutch. Dr Shadman also earned an MPH degree from UW and was a fellow for the National Cancer Institute’s cancer research training program at Fred Hutch, where he studies cancer epidemiology.
Dan Lenihan
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Dr Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.